Beirut: The American University of Beirut named Fadlo Khuri as its new president Thursday.
Dr. Khuri, who will succeed former President Peter Droman, is presently the Chairman of the Department of Hematology and Medical Oncology at Emory University’s School of Medicine and holds the Roberto C. Goizueta Distinguished Chair for Cancer Research, according to a statement released by AUB’s media office.
Khuri, who was recently appointed executive associate dean for research at EUSM, also serves as deputy director for the Winship Cancer Institute at the university.
“It is a genuine honor and a privilege to have been selected to lead AUB into its 150th year. The legacy of this remarkable, world class institution is evident in the breadth and depth of contributions its faculty, students and alumni have made to every aspect of life in Lebanon, the region and the world,” Khuri said.
Khuri who will serve as the university's 16th president, was born in Boston, Massachusetts and brought up in Beirut, where he attended AUB from 1981-82. He moved to the U.S. in 1982, and earned his bachelor's degree from Yale University, in New Haven, Connecticut and his MD from Columbia University, College of Physicians and Surgeons, in New York.
He completed his residency in Internal Medicine at the Boston City Hospital and his fellowship in Hematology and Medical Oncology at the Tufts-New England Medical Center.
An accomplished molecular oncologist, Khuri's clinical expertise and research are focused on the development of molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for patients with lung and aerodigestive cancers.
Incumbent President Peter Dorman, who announced his intention to resign in June of last year, will take a sabbatical with the intention to return to the AUB faculty in 2016.
No comments:
Post a Comment